Robert Dillard
Robert Dillard is a contributing writer with Cancer Nursing Today and its parent company, Mashup Media LLC. As a medical writer and editor, Mr. Dillard is experienced at producing high-quality clinical articles, blog articles, news releases, whitepapers, and a wide array of educational and promotional content pieces. Mr. Dillard has been writing in the health care space for over seven years and previously served as a public relations specialist, a field in which he holds a Bachelor of Arts degree from Rowan University. He lives in Manalapan, NJ, with his son.
Articles by Robert Dillard
Universal extracellular vesicles (EVs) and PD-L1-positive extracellular vesicles may be viable biomarkers for predicting ...
A study published in the British Journal of Cancer found that analyzing small extracellular vesicles (sEVs) could be useful ...
Researchers of a study developed an International Prognostic Index-based immune prognostic model (IPI-IPM) that yields robust ...
A study shows that label-free surface-enhanced Raman spectroscopy (SERS) in combination with descriptive analysis may ...
A study sought to explore the impact of intratumoral T-cell receptor (TCR) repertoire on interim positron emission tomography ...
Previous studies have shown that lymphomatous effusions in patients with diffuse large B-cell lymphoma (DLBCL) are linked ...
The results of a study indicate that artesunate (ART), a water-soluble derivative of artemisinin, may help in fighting ...
A study assessed clinical biological features in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients to ...
A study which appeared in Annals of Palliative Medicine aimed to evaluate the prognostic significance of the advanced lung ...
A study assessed clinical characteristics and prognosis among patients with primary bone diffuse large B-cell lymphoma ...
A study shows that CREB binding protein (BP) inactivation may serve as robust therapeutic strategy in diffuse large B-cell ...
A study found that positron emission tomography with 18F-Fludeoxyglucose (FDG) integrated with computed tomography (18F-FDG ...
A study aimed to assess the clinicopathological characteristics of diffuse large B-cell lymphoma (DLBCL) among affected ...
Hematopoietic cell transplantation (HCT) may benefit therapy-sensitive patients with diffuse large B-cell lymphoma Richter ...
Patients with diffuse large B-cell lymphoma (DLBCL) and low socioeconomic status (SES) have worse survival outcomes, ...
A study found that the central nervous system international prognostic index (CNS-IPI), which is widely used for the ...
Short-term calorie reduction (SCR) may benefit patients with diffuse large B-cell lymphoma (DLBCL) according to a study ...
Some studies suggest that using 500 mg/m2 rituximab combined with a regimen of cyclophosphamide, doxorubicin, vincristine, ...
Researchers sought to assess the impact of Hepatitis C virus (HCV) in patients with diffuse large B-cell lymphoma (DLBCL). In ...
A study analyzed differently expressed microRNAs (miRNAs) that may serve as therapeutic targets in diffuse large B-cell ...
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.